--- title: "Alloy speeds up timeline for complex fibrosis targets, completing successful antibody discovery collab with Mediar." type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/274645487.md" description: "Alloy Therapeutics Inc., a biotechnology company based in Boston, has recently completed a successful antibody discovery collaboration with Mediar Therapeutics. Through the utilization of Alloy's ATX-Gx™ human transgenic mouse platform, as well as advanced genetic immunization techniques and AI/ML-enabled discovery workflows, Alloy was able to provide a set of unique binders targeting a challenging new target. This collaboration has marked a significant milestone for Alloy, showcasing its commitment to expanding access to cutting-edge drug discovery technologies." datetime: "2026-02-03T11:08:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274645487.md) - [en](https://longbridge.com/en/news/274645487.md) - [zh-HK](https://longbridge.com/zh-HK/news/274645487.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274645487.md) | [English](https://longbridge.com/en/news/274645487.md) # Alloy speeds up timeline for complex fibrosis targets, completing successful antibody discovery collab with Mediar. Alloy Therapeutics Inc., a biotechnology company based in Boston, has recently completed a successful antibody discovery collaboration with Mediar Therapeutics. Through the utilization of Alloy's ATX-Gx™ human transgenic mouse platform, as well as advanced genetic immunization techniques and AI/ML-enabled discovery workflows, Alloy was able to provide a set of unique binders targeting a challenging new target. This collaboration has marked a significant milestone for Alloy, showcasing its commitment to expanding access to cutting-edge drug discovery technologies. ### 相關股票 - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [Medicenna Therapeutics Corp. (MDNAF.US)](https://longbridge.com/zh-HK/quote/MDNAF.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md) - [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md) - [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [Allarity Therapeutics (ALLR.US)](https://longbridge.com/zh-HK/quote/ALLR.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Aligos Therapeutics (ALGS.US)](https://longbridge.com/zh-HK/quote/ALGS.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [Allogene Therapeutics (ALLO.US)](https://longbridge.com/zh-HK/quote/ALLO.US.md) ## 相關資訊與研究 - [bioAffinity Launches Major Lung Cancer Detection Study](https://longbridge.com/zh-HK/news/278565253.md) - [Galecto Rebrands as Damora Therapeutics with New Ticker](https://longbridge.com/zh-HK/news/278556054.md) - [Pfizer Inc. Reports Positive Phase 2 Results for tilrekimig (PF-07275315) in Atopic Dermatitis](https://longbridge.com/zh-HK/news/278448836.md) - [CSP International Publishes Disclosure on V2D Création Acquisition](https://longbridge.com/zh-HK/news/278778570.md) - [Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data](https://longbridge.com/zh-HK/news/278566951.md)